Interferon (IFN): A Comprehensive Overview

Interferon (IFN) is a class of cytokines with antiviral, immunomodulatory, and antitumor activities. Based on structural, receptor, and functional differences, IFNs are primarily categorized into Type I, Type II, and Type III. Additionally, the recently discovered Type IV IFN (IFN-λ4) has garnered attention.

Simplified Diagram of Virus-Blocking IFN Signaling Pathway

Simplified Diagram of Immunomodulatory IFN Signaling Pathway

Type I Interferons (Type I IFNs)

Type I IFNs constitute the largest IFN family, comprising IFN-α, IFN-β, IFN-ω, IFN-ε, and IFN-κ, which function via the IFNAR1/IFNAR2 receptor complex.

Key Members and Their Functions

IFN-α (13 subtypes):

Antiviral Activity: Induces hundreds of interferon-stimulated genes (ISGs) to inhibit viral replication.
Immunomodulation: Activates dendritic cells (DCs), NK cells, and T cells, enhancing antigen presentation.
Clinical Applications: Treats chronic hepatitis B, multiple sclerosis, and certain cancers (e.g., hairy cell leukemia).

IFN-β:

Neuroprotection: Inhibits inflammatory demyelination; first-line therapy for multiple sclerosis (MS).
Antiviral Activity: Stronger paracrine signaling than IFN-α.

IFN-ω:

Functions similarly to IFN-α but is specifically expressed during certain viral infections (e.g., HIV).

IFN-ε/IFN-κ:

Mucosal Immunity: IFN-ε is constitutively expressed in genital mucosa, providing basal antiviral defense; IFN-κ is produced by keratinocytes and participates in skin immunity.

Type II Interferon (Type II IFN)
Comprising solely IFN-γ, which acts via the IFNGR1/IFNGR2 receptor, primarily produced by activated T cells, NK cells, and macrophages.

Functions of IFN-γ

Core of Immune Regulation:

Activates macrophages to promote pathogen clearance (e.g., Mycobacterium tuberculosis).
Enhances MHC I/II expression, bridging innate and adaptive immunity.

Antitumor Activity:

Inhibits angiogenesis and promotes tumor cell apoptosis.

Double-Edged Sword in Inflammation:

Overproduction may lead to autoimmune diseases (e.g., rheumatoid arthritis).

Type III Interferons (Type III IFNs, IFN-λ)

Including IFN-λ1 (IL-29), IFN-λ2 (IL-28A), IFN-λ3 (IL-28B), and IFN-λ4, functioning via the IFNLR1/IL10R2 receptor, mainly expressed in mucosal epithelial cells.

Functional Characteristics

Mucosal-Specific Defense:

Efficient antiviral activity in respiratory, intestinal, and hepatic tissues (e.g., HCV, influenza) with fewer inflammatory side effects than Type I IFNs.

Controversy over IFN-λ4:

Some individuals lack functional IFN-λ4 due to genetic mutations, correlating with spontaneous hepatitis C clearance.

Other IFN-Related Molecules

Limitin:

A Type I IFN analog discovered in mice with antiviral and B cell-suppressive functions.

Non-Canonical IFNs:

e.g., IFN-ζ (specifically expressed in mammalian placenta); functions under investigation.

Through multi-layered immune regulation, the IFN family serves as a critical target in the treatment of infections, tumors, and autoimmune diseases. As precision medicine advances, their therapeutic potential will continue to expand.

References

Pestka, S. (2007). The interferon receptors. Springer.

Lazear, H. M. (2019). Immunity.

Maria Rosaria Capobianchi; Elena Uleri; Claudia Caglioti; Antonina Dolei. (2015). Type I IFN family members: Similarity,

differences and interaction. Cytokine & Growth Factor Reviews.

Hideo Negishi, Tadatsugu Taniguchi, Hideyuki Yanai. (2018). The Interferon (IFN) Class of Cytokines and the IFN

Regulatory Factor (IRF) Transcription Factor Family. Cold Spring Harbor Laboratory Press.

Technical Articles